Sleep and Cognition in Breast Cancer Survivors
A Potential Treatment Option for Perceived Cognitive Impairment in Survivors of Breast Cancer
Breast cancer survivors (BCS) experience prevalent and persistent co-occurring symptoms of insomnia and perceived cognitive impairment (PCI). Cognitive Behavioral Therapy for insomnia (CBT-I) is highly effective. Given the association between these symptoms, this feasibility study explored the impact of CBT-I on PCI in BCS. In this study, 10 BCS with insomnia disorder and PCI received 7 weekly individual sessions of CBT-I. This study concludes that CBT-I is feasible and may be a potentially efficacious and durable treatment option for PCI in BCS, but future controlled trials with larger samples are needed.
Study Findings
Click below to read the publications from this study:
Published Abstracts
SLEEP 2020 - 1030 An Exploration of the Impact of Cognitive Behavioural Therapy of Insomnia (CBT-I) on Perceived Cognitive Impairment in Breast Cancer Survivors
SLEEP 2020 - 1031 Exploring the Impact of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Daytime Productivity in Survivors of Breast Cancer
CAPO 2020 - 85 | A Single Arm Study Investigating the Impact of Cognitive Behavioural Therapy for Insomnia on Perceived Cognitive Impairment in Survivors of Breast Cancer
Investigators
Primary Investigator:
Sheila N. Garland, PhD
(Department of Psychology, Faculty of Science and Discipline of Oncology, Faculty of Medicine)
Graduate Student Masters Thesis:
Nyissa Walsh, MSc (Department of Psychology, MUN)
Co-Investigators:
Renee Lester, MD, (Discipline of Oncology, Faculty of Medicine, MUN)
Joy McCarthy, MD, (Discipline of Oncology, Faculty of Medicine, MUN)
Kara Laing, MD, (Discipline of Oncology, Faculty of Medicine, MUN)
Supported by a grant from The Beatrice Hunter Cancer Research Institute
